Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 640 participants.

Also called NCT06400940

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 640 participants (planned count) (from the registry)
Sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (from the registry)
Registry
  • NCT NCT06400940
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06400940. Randomized; no masking; primary purpose treatment. Start 2023-08-17 (actual); primary completion 2026-08-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
Condition
Intracranial Aneurysm
Intervention (Drug)
ticagrelor (tablets, 180 mg) or prasugrel (tablets, 10 mg).
Intervention (Drug)
combination of clopidogrel (tablets, 75 mg) and acetylsalicylic acid (ASA, tablets, 100 mg) or a combination of ticagrelor (tablets, 180 mg) and ASA (tablets, 100 mg).
Lead sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (class: other)

Record details

Record id
cardio:ct-nct06400940
Content hash
d438b0a1c4c603b3d7ff4b1c8f9073b4d6ced5fc9f7a4bb43c1ad5d22786cc61